west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "癫痫性脑病" 17 results
  • Dravet综合征——从癫痫性脑病到离子通道病

    编码电压门控钠通道α1亚单位(α1 subunit of the voltage gated sodium channel, SCN1A)的基因突变与多种癫痫综合征相关, 包括相对较轻的家族性全身性癫痫伴热性惊厥附加症(Genetic epilepsy with febrile seizures plus, GEFS+), 到严重的婴儿发病的Dravet综合征。已有证据显示, 大脑中不同神经元网络中SCN1A功能障碍的指向一个离子通道病模型, 使得Dravet综合征的神经科特征超越了单纯的发作相关损伤。基因改变的临床表型会随着其严重程度、个体的基因背景, 以及环境因素的不同而不同, 并且会根据离子通道的分布影响一系列神经元网络。原本就脆弱的系统可能很容易继发恶性事件, 如癫痫持续状态。离子通道模型预示着药物治疗并修复受损的γ-氨基丁酸(γ-aminobutyric acid, GABA)能神经传递也许不仅能预防癫痫发作, 还能治疗合并症。原综述研究关于在Dravet综合征中SCN1A突变的致病性, 及其对更广泛疾病表型的影响的最新证据, 并讨论了对这些特殊基因型的认识是否能影响临床实践。基因技术正在以前所未有的速度发展着, 将增加人们关于新的基因和基因间相互作用网络的知识。临床医生和遗传学家必将密切合作, 以保证基因测试结果能得到很好的解释和咨询服务

    Release date: Export PDF Favorites Scan
  • 吡哆醇(胺)氧化酶缺乏的研究进展

    吡哆醇(胺)氧化酶(Pyridox(am)ine-5-phosphate oxidase, PNPO)缺乏是一种由编码PNPO的PNPO基因突变引起的罕见常染色体隐性遗传的先天性代谢缺陷, 其典型临床表现是新生儿癫痫性脑病, 抗癫痫药物治疗无效, 磷酸吡哆醛或吡哆醇可改善症状, 目前尚无特异性生物化学标志物, 确诊需要检测PNPO基因。PNPO缺乏作为一种可治疗的潜在病因, 应包含在大田原综合征和新生儿肌阵挛性脑病的鉴别诊断中。未经磷酸吡哆醛或吡哆醇治疗的PNPO缺乏患儿可导致早期死亡, 而早期正确治疗者神经发育可正常。

    Release date:2016-10-02 06:51 Export PDF Favorites Scan
  • 热性感染相关性癫痫综合征的诊治研究进展

    热性感染相关性癫痫综合征(Febrile infection-related epilepsy syndrome,FIRES)是近年来逐渐被人们认识的最严重癫痫性脑病之一,主要特征是急性热性疾病后数天出现难治性癫痫持续状态或成簇癫痫发作,并随即演变为局灶性发作为主的药物难治性癫痫和认知损害等神经心理学障碍。FIRES的病因和发病机制尚不完全清楚,可能是一种免疫性但不是自身免疫性疾病。其诊断主要依据其临床特征和排除其他相关性疾病,治疗十分困难,预后不良。但FIRES的早期诊断至关重要,可以指导治疗,尤其是选择最佳的一线治疗,有助于改善预后。

    Release date:2017-11-27 02:36 Export PDF Favorites Scan
  • 癫痫性脑病:对一个重要临床概念的使用和滥用

    癫痫性脑病(Epileptic encephalopathy, EE)是指癫痫活动对脑功能的不良影响超过其潜在的病因。对其潜在的机制知之甚少,但最近的研究表明癫痫发作和发作间期癫痫样放电可以破坏暂时和永久支撑认知功能的神经网络分布。EE只是癫痫中影响发育的多种因素之一。EE所致的认知损害通常难以与潜在的病因或是抗癫痫药物的不良反应区分。这种困难导致越来越多地使用EE来概括“严重的”癫痫综合征或是与严重的癫痫以及智力障碍相关的病因,而不管癫痫影响认知功能的证据。文献中不但使用EE这个术语来描述癫痫活动导致认知损害的过程,也将其归为一类严重的癫痫综合征,这导致了混淆。提议EE这一术语应该严格用于普遍的癫痫过程影响发育这个中心概念,而应该避免使用EE作为分类方式。需要另一个术语来概括广泛且异质的有严重癫痫和智力障碍的患者,其机制可能是未知的,但是通常与潜在的遗传性、代谢性或结构性病因密切相关。提高对EE致病机制的认识至关重要,可能有利于明确生物标志物用于早期诊断和治疗。

    Release date:2017-11-27 02:36 Export PDF Favorites Scan
  • 突触融合蛋白结合蛋白-1 基因相关脑病的临床表型及基因研究进展

    癫痫性脑病是婴儿期和儿童早期严重的脑部疾患,其中 70% 癫痫性脑病与遗传因素相关。突触融合蛋白结合蛋白-1(Syntaxin-binding protein 1,STXBP1)基因编码 STXBP1,其发生突变可影响突触囊泡融合及神经递质释放,是引起癫痫性脑病的常见致病基因。STXBP1 基因突变的致病机制是单倍剂量不足,STXBP1 的补充或激活可能是一种潜在的精准治疗策略。文章对近年来报道的 STXBP1 基因相关脑病的临床表型、基因研究等进展进行综述。

    Release date:2018-05-22 02:14 Export PDF Favorites Scan
  • 突触融合蛋白结合蛋白 1 基因与癫痫性脑病的研究进展

    癫痫性脑病(Epileptic encephalopathy,EE)是一类由难治性癫痫极度异常脑电活动导致的脑部疾病。近年来随着分子遗传学的进步,越来越多的研究表明突触融合蛋白结合蛋白 1(Synaptotagmin binding protein 1, STXBP1)基因突变与 EE 有关。文章对 EE 的病因及病理生理学机制进行综述,从而提高临床医生对 EE 的认识,并探讨将 STXBP1 作为靶点治疗 EE 的可能性,为临床治疗 EE 提供依据和指导。

    Release date:2018-09-18 10:17 Export PDF Favorites Scan
  • DNM1 gene pathogenic variation in 3 cases with early infantile epileptic encephalopathy-31 and Literature review

    ObjectiveTo explore the clinical, genetic and prognostic features of early infantile epileptic encephalopathy caused by DNM1 gene pathogenic variations.MethodsClinical phenotype, genotype and prognosis of 3 individuals with de novo variants in DNM1 gene were analyzed retrospectively. Through using “Dynamin-1” or “DNM1” as key words to search literature at database of China National Knowledge Infrastructure, Wanfang, PubMed and OMIM. Genotype-phenotype correlations were analyzed by analysis of variance (ANOVA).ResultAmong the 3 patients, 1 female and 2 males. 2 cases with epileptic spasm and 1 case with focal clonic seizure or secondary generalized tonic-clonic seizure were manifested with onset age from 2 to 17 months. De novo variants at NM_004408.4: c.415 G>A(P. Gly 139Arg) in 2 inviduals and NM_004408.4: c.545 C>A(P. Ala 182Asp)in 1 invidual of DNM1 gene were identified by gene testing. After follow-up at age of 2~3 years, all patients were presented with hypotonia, severe intellectual disability, non-verbal, non-ambulatory, drug-resistant epilepsy and feeding difficulties. 36 cases with pathogenic DNM1 variants were reported by far, totally 39 cases were included. Of the 39 patients, hypotonia were found to be independent of the locus of genetic variants, while those inviduals with variants in the GTPase and middle domains almost presented severe or profound intellectual disability and epilepsy. 31 patients diagnosed with epilepsy and complete clinical data were further analyzed, epileptic spasm was the most common types of seizure. Absent seizure was significantly more common in those patients with variants in the GTPase domains (P=0.02), compared to those patients with variants in the middle domains. No statistical differences were found in gender, onset age, other types of seizure and drug treatment response between variants in the GTPase and middle domains.ConclusionHypotonia, early onset epilepsy, severe intellectual and movement disability were the common features in patients with DMN1 related encephalopathy. Epileptic spasm was the most common types of seizure, no significant differences were found in the phenotype between the GTPase and middle domains expect for absent seizure. Our patients also presented with feeding difficulties.

    Release date:2021-04-25 09:50 Export PDF Favorites Scan
  • DNM1基因变异所致发育性癫痫性脑病一例

    Release date: Export PDF Favorites Scan
  • 生酮饮食治疗RHOBTB2基因相关发育性癫痫性脑病一例并文献复习

    Release date: Export PDF Favorites Scan
  • Advances in surgical treatment of early-infantile development epileptic encephalopathy

    Severe psychomotor developmental delay resulting from early postnatal (within 3 months) seizures can be diagnosed as Early-Infantile Developmental and Epileptic encephalopathies (EIDEE). Its primary etiologies include structural, hereditary, metabolic and etc. The main pathogenesis may be related to the inhibition of normal physiological activity of the brain by abnormal electrical activity and the damage of the brain neural network. Ohtahara syndrome and Early Myoclonic Encephalopathy (EME) are typical types of EIDEE. The principle of treatment is to improve the cognitive and developmental function by controlling frequent seizures. When the seizure is difficult to control with drugs, surgical evaluation should be performed as soon as possible, and surgical treatment is the first choice for patients suitable for surgery. The types of surgery can be divided into excision surgery, dissociation surgery, neuromodulation surgery and etc. The current status of surgical treatment of EIDEE was described, and the curative effect of surgical treatment was explored, so as to help clinicians choose appropriate treatment methods.

    Release date: Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content